A retrospective single-center study of 176 thyroid surgery patients found that malignancy despite benign Bethesda II cytology ...
A family of mutations seen in about 20% of human cancers drives malignancy by changing the accessibility of genes to a ...
A new study reports that hexokinase 2 promotes malignant phenotypes in colorectal cancer by enhancing UBE3A-dependent ...
TransCode has engaged Tungsten Advisors as the Company's exclusive strategic financial advisor in connection with the process ...
A melanoma expert discusses gaps in dermoscopy education, cognitive bias during skin examinations, and strategies to improve ...
Capitalize on rising biopsy volumes with minimally invasive, image-guided and AI-enhanced systems that improve accuracy, patient comfort and workflow efficiencyDublin, Oct. (GLOBE NEWSWIRE) -- "U.S.
According to DelveInsight's analysis, the chondrosarcoma market size was found to be ~USD 15 million in the 7MM in 2025, and it is projected to grow at a CAGR of 16% during 2026–2036. Among the 7MM, ...
A Phase 3 trial demonstrates superior survival with ivonescimab in advanced biliary tract cancer. Read more about the ...
Roche launches VENTANA BAP1 (SP527) test for differential diagnosis of mesothelioma: Basel Thursday, October 29, 2026, 10:00 Hrs [IST] Roche announced the global launch of the VEN ...
Before AI ‘Destroys’ the world, it’ll save you from cancer and other maladies, finds Satyen K. Bordoloi During the worst days ...
A family of mutations seen in about 20% of human cancers drives malignancy by changing the accessibility of genes to a particular regulatory protein ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results